VEGFR1 signaling in retinal angiogenesis and microinflammation.

Uemura A. et al.  Progress in Retinal and Eye Research Feb 25:100954. (2021)

Three new ANBITION patents filed on November 30th, 2020

Italian patent n° 102020000028952, n° 102020000028964 and n° 102020000028976. 

Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Tarallo V. et al, International Journal of Molecular Sciences 21:410 (2020)